Entero Therapeutics, Inc.
ENTO
$1.91
$0.010.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -998.30K | -1.26M | -12.24M | -2.58M | -8.81M |
| Total Depreciation and Amortization | -- | -- | -34.30K | 1.30K | 35.30K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 5.80K |
| Total Other Non-Cash Items | 0.00 | 126.80K | 10.70M | 201.00K | 5.17M |
| Change in Net Operating Assets | 943.40K | 314.20K | 1.40M | 530.20K | 147.90K |
| Cash from Operations | -54.90K | -818.60K | -171.50K | -1.85M | -3.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | 0.00 | 700.00K | -- | 0.00 | 31.80K |
| Total Debt Repaid | -- | -- | 0.00 | -177.60K | -241.00K |
| Issuance of Common Stock | -- | -- | 0.00 | 1.73M | 890.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 700.00K | -31.80K | 1.55M | 681.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.90K | -118.60K | -203.30K | -295.70K | -2.77M |